XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Organization, Nature of the Business, COVID-19, Clinical Hold and Basis of Presentation - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
May 10, 2022
Aug. 14, 2020
Jul. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Net loss       $ 8,943,000 $ 12,088,000  
Accumulated deficit       (125,193,000)   $ (116,250,000)
Cash and cash equivalents       $ 62,600,000    
ATM Offering [Member] | Common Stock [Member]            
Issuance of common stock | shares     2,342,720      
Proceeds from issuance of common stock     $ 20,500,000      
ATM Offering [Member] | Common Stock [Member] | Subsequent Event [Member]            
Gross sales proceeds under sales agreement remaining amount $ 29,200,000          
ATM Offering [Member] | Common Stock [Member] | Maximum [Member]            
Aggregate sale of shares of our common stock   $ 50,000,000